Neuronal acetylcholine receptors (AChFls), which bind nicotine with high affinity but do not bind cu-bungarotoxin (aBgt), have recently been immunoaffinity-purified from chicken (Whiting and Lindstrom, 1986a) and rat brain using monoclonal antibodies (mAbs). Here we report the characterization of nicotinic AChRs of bovine and human brain using as probes mAbs prepared to AChRs from rat brain. Both the human and bovine brain AChRs exhibit high affinity for L-nicotine (K, = 18 nM for bovine AChR and Ki = 6.5 nM for human AChR) and other cholinergic agonists, relatively lower affinity for cholinergic antagonists, and do not bind crBgt. These AChRs are affinity-labeled with bromoacetylcholine and 4-(hl-maleimido)benzyltrimethylammonium iodide (MBTA) after reduction with dithiothreitol, indicating that amino acid residues homologous to cysteines 192 and 193 of cx subunits of Torpedo electric organ AChRs are conserved.
Immunoaffinity-purified bovine brain AChR consists of 2 types of subunit, M, 50,600 and M, 74,400. The M, 74,400 subunit was affinity-labeled with 3H-MBTA, indicating that it contains the ACh binding site. Thus, mAbs have proven to be excellent probes for these proteins, and have been used to show that neuronal nicotinic AChRs of chickens, rats, and cattle are macromolecules approximately 10 S in size and composed of only 2 kinds of subunits: an AChbinding subunit and a structural subunit.
There is much behavioral, electrophysiological, and pharmacological evidence demonstrating the existence of nicotinic acetylcholine receptors (AChRs) in avian and mammalian brain (see Martin, 1986; Wonnacott, 1987; and Lindstrom et al., 1987, for review) . Until recently, the purification and molecular characterization of these neuronal AChRs has not been possible owing to the lack of suitable biochemical probes. The snake toxin a-bungarotoxin (aBgt) proved an invaluable tool for characterizing electric organ and muscle AChRs (see Popot and Changeux, 1984) but there is now much evidence to indicate that it does not bind to avian and mammalian neuronal AChR, which gate cation channels (see Chiappinelli, 1985) and is therefore not a useful probe. We have used monoclonal antibodies (mAbs) to purify and characterize neuronal nicotinic AChRs. A mAb prepared to AChRs from electric organ (mAb 35) cross-reacted with a nicotinic AChR in chicken brain Swanson et al., 1983) . The immunoaffinity-purified AChR consisted of 2 types of subunit (Whiting and Lindstrom, 1986a) . Affinitylabeling with 3H-4-(N-maleimido)benzyltrimethylammonium iodide OH-MBTA) showed that the M, 59,000 subunit type bound ACh, while the M, 49,000 subunit type played a structural role .This AChR bound 3H-nicotine and other cholinergic agonists with high affinity, bound cholinergic antagonists with relatively low affinity, and did not bind otBgt (Whiting and Lindstrom, 1986b) . mAb 35 also identified the nicotinic AChR on chick ciliary ganglion neurons (Jacob et al., 1984; Smith et al., 1985 Smith et al., , 1986 Berg, 1986, 1987) . Antisera prepared to the AChR from chicken brain specifically blocked the function of AChRs on chick ciliary ganglia (Stollberg et al., 1986) , suggesting that the AChRs of brain were also functional AChRs. mAbs prepared to AChR from chicken brain identified a second AChR subtype with similar or identical structural subunits, but ACh-binding subunits of A4, 75,000 . Chicken brain-derived mAb 270, prepared to AChRs, crossreacts with AChRs from rat brain. This mAb has proven to be an extremely useful tool, and has been used to histologically locate (Swanson et al., 1987) , purify, and characterize nicotinic AChRs from rat brain Lindstrom, 1986b, 1987a) and to identify a functional AChR on rat PC12 cells (Whiting et al., 1987d) . Immunoaffinity-purified AChRs from rat brain also consist of 2 types of subunits, a structural subunit A& 5 1,000 and an ACh-binding subunit of M, 79,000. Like AChRs from chicken brain, the rat brain AChR has high affinity for nicotine and other cholinergic agonists, relatively lower affinity for antagonists, and does not bind cYBgt (Whiting and Lindstrom, 1986b) .
In an alternative approach to studying these neuronal nicotinic AChRs at the molecular level, several groups have used complementary DNA (cDNA) probes coding for subunits of muscle AChRs to isolate cDNA clones that code for putative neuronal AChR subunits by low-stringency cross-hybridization (Boulter et al., 1986; Goldman et al., 1987; Deneris et al., 1988; Nef et al., 1988; Schoepfer et al., 1988; Wada et al., 1988) . Amino acid-sequence analysis of the subunits of immunoaffinity-purified AChRs has identified the AChR subunits for which many of these cDNAs code: the rat cDNA (~4 (Goldman et al., 1987) codes for the 79,000 A& ACh-binding subunit of rat brain AChR ; the chicken cDNA cu4 (Nef et al., 1988 ; P. J. Whiting, R. Schoepfer, and J. M. Lindstrom, unpublished observations) codes for the 75,000 M, ACh-binding subunit of chicken brain AChRs; the rat cDNA 02 codes for the 5 1,000 M, structural subunit of AChRs from rat brain (Schoepfer et al., 1988) ; and the chicken cDNA not (Nef et al., 1988) codes for the 49,000 M, structural subunit of AChRs from chicken brain (Schoepfer et al., 1988) . Thus the mAb approach and the cDNA approach are beginning to converge.
The mAbs prepared to AChRs from chicken brain exhibited little or no cross-reactivity with AChRs from bovine and human brain . To overcome this problem, we have prepared a small library of mAbs to AChRs from rat brain, several of which exhi,bit excellent binding to AChRs from bovine and human brain. These mAbs have allowed the purification and characterization of these AChRs, as described below.
Materials and Methods
AChR purification. AChRs from rat brain were purified by immunoaffinity chromatography using mAb 270 coupled to Sepharose-CL4B (8 mg protein/ml Sepharose), as has been described previously .
AChRs from bovine brain were purified by immunoaffinity chromatography using mAb 295 (see below) coupled to AFC resin (New Brunswick Scientific). Briefly, a bovine brain (obtained from a local abbatoir and stored at -70°C) was pulverized into small pieces while still frozen, and then 150-200 gm amounts were homogenized and the membranes isolated exactly as described previously (Whiting and LindStrom, 1986a) . The membranes were then extracted for 2 hr at 4°C in 1 vol of 2% Triton X-100 in 50 mM Tris. pH 7.2. 1 mM EGTA. 1 mM EDTA, 5 mM iodacetamide, 5 mM benzamidine, and 2 mM phenylmethanesulfonyl fluoride (PMSF). The extract was centrifuged at 140,000 x gfor 1 hr in a Beckman Ti50.2 rotor, the clear supernatant collected, and the extract then gently shaken for 15 hr at 4°C with 3 ml of mAb 295-AFC resin (6.7 mg protein/ml resin). The resin was then loaded into a 10 ml column and washed successively with approximately 200 ml of 10 mM Na phosphate, pH 7.5, 100 mM NaCl (PBS) containing 0.5% Triton X-100, 100 ml of 10 mM Na phosphate, pH 7.5, 1 M NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% Triton X-100, and finally with 20 ml of 20 mM Tris, pH 7.5, 100 mM NaCl, with 0.1% Thesit detergent (Calbiochem). Bound AChR was eluted with 2-column volumes of AFC elution medium (New Brunswick Scientific) and dialyzed against 4 liters of 20 mM Tris, pH 7.5, 100 mM NaCl, with 0.05% Thesit.
Purified AChRs from rat and bovine brain were radioiodinated as previously described (Whiting and Lindstrom, 1986a) by the lactoperoxidase-alucose oxidase method (BioRad) . and keut at 4°C in PBS. 0.5% Triton X1100, containing 1 mM Na azide and 10 n&ml fl-lactoglobulin.
Detergent extracts of chicken brain, human brain, and rat muscle were also prepared as previously described (Whiting and Lindstrom, 1986a) .
Immunization and spleen cell fusion. Female Lewis rats (6-8 weeks old) were immunized with immunoaffinity-purified rat brain AChR, both intact and denatured, in SDS, emulsified in 100-200 ~1 of complete Freund's adjuvant (CFA). The rat that gave rise to the mAbs described was immunized intraperitoneally in PBS on day 1 with 10 pmol AChR in CFA, on day 17 with 5 pmol AChR (SDS-denatured) in CFA, on day 3 1 with 45 pmol AChR (half of which was SDS-denatured) in CFA, and finally on day 45 with 20 pmol AChR (half SDS-denatured). Five d later, the rat was killed and its spleen cells fused with the mouse myeloma cell line S194 1 S.XXO.BUl, using 50% polyethylene glycol 4000 (Merck), as described in detail elsewhere (Hochschwender et al., 1985) . Culture supematants were screened for binding to Y-labeled rat brain AChR by indirect immunoprecipitation using goat anti-rat IgG (Lindstrom et al., 198 1) . Supematants that were positive (greater than twice background binding) upon retesting, and that, upon subsequent rescreening, exhibited binding to 3H-nicotine-labeled AChRs in detergent extracts of chicken brain (see below), were selected for recloning. Hybridoma cells were cloned directly in agarose (Hochschwender et al., 1985) and then grown in bulk in Iscove's medium, containing 1% fetal calf serum. Supematants from mass cultures were concentrated to about 300 ml using a Millipore Minitan concentrator and the immunoglobulin fraction isolated by precipitation with 18% sodium sulfate, and then dialyzed against PBS containing 10 mM sodium azide. mAb 295 was purified by chromatography upon S-Sepharose (Pharmacia). Briefly, 7 ml of concentrated mAb 295 were dialyzed against 50 mM morpholine-ethanesulfonic acid, pH 6, 5 mM NaCl, and then applied to a 0.5 x 10 cm column of S-Sepharose. Bound mAb was eluted with the same buffer containing 1 M NaCl; 127 mg of mAb was recovered.
'H-Nicotine binding assay. Antibody binding to AChRs in crude detergent extracts of brain was determined as described previously (Whiting and Lindstrom, 1986b) . Briefly, detergent extract (200-600 ~1) was shaken gently for 15 hr at 4°C with 100 ~1 of culture supematant or an appropriate amount of mAb or serum, and 20-30 ~1 of a 1: 1 slurry of goat anti-rat IgG Sepharose (8-l 2.5 mg IgG/ml gel). After washing twice with 1 ml of PBS containing 0.5% Triton X-100, the aliquots were incubated for 15 min at room temperature in 50 ~1 of 20 nM 'H-nicotine m-N-methyl 3H-nicotine, sp act 68.6 Ci/mmol, obtained from NEN in the same buffer, and then rapidly washed 4 times at 4°C with 1 ml of ice-cold PBS, 0.5% Triton X-100 by resuspending in the buffer and centrifuging for 20 set at 10,000 x g in a microfuge. Bound protein was then eluted by incubating the gel for 15 min with 100 pl of 2.5% SDS, 5% P-mercaptoethanol, and then sampling into 5 ml of scintillant [5% Biosolve (Beckman), 4% Liquifluor (NEN) in toluene]. Radioactivity was determined by scintillation counting. Specific binding was determined by subtraction of binding in the absence of antibody.
Polyacrylamide gel electrophoresis and western blot analysis. SDS-PAGE and western blotting of protein samples were performed as previously described (Whiting and Lindstrom, 1986a) , except that when probing western blots with antibodies, all incubations were carried out in PBS, 0.5% Triton X-100, containing 5% (wt/vol) milk powder (Carnation) rather than bovine serum albumin. Polyacrylamide gels were silver-stained for protein (Oakley et al., 1980) . Polyacrylamide gels containing lZ51-protein were autoradiographed for a8 hr at -70°C using preflashed Kodak X-Omat AR film and an intensifying screen.
Enzymic digestion of 12SI-labeled bovine brain AChR subunits. 12sI-Subunits were produced by preparative electrophoresis of the radiolabeled AChR and subsequent elution of the subunits (Whiting et al., 1986a) . rLSI-Subunits were treated with endoglycosidase-H (Miles) or Staphylococcus V8 protease (Miles), as has been described previously (Whiting and Lindstrom, 1986a) .
Results
Library of mAbs to AChRs from rat brain A library of 9 mAbs to AChRs from rat brain was prepared, the properties of which are shown in Table 1 .
All of the mAbs bound 88-100% of the 3H-nicotine binding sites in detergent extracts of rat brain (data not shown). Additionally, AChRs immunoaffinity-purified from rat brain using mAbs 290, 295, and 299 had the same 2-subunit structure as AChRs purified on mAb 270 (data not shown). These data argue against the existence of large amounts of any subtype of AChRs with a high affinity for nicotine with major differences in subunit structure, such as the AChR subtypes we identified in chicken brain .
Most of the mAbs proved to be conformation-dependent; only mAbs 292, 293, and 299 bound to denatured AChR subunits (Table 1 ). However, it is possible to predict the subunit specificity of some of these mAbs by determining the proportion of 3H-nicotine binding sites depleted from a detergent extract of adult chicken brain. Adult chicken brain contains approximately equal amounts of 2 AChR subtypes that have very similar or identical structural subunits, but different ACh-binding subunits (M, 59 ,000 or 75,000) . The structural and M, 75,000 ACh-binding subunits of chicken brain AChRs are homologous to the structural and ACh-binding subunits of rat brain AChR . The chicken brain AChR subtypes can be distinguished by mAb 35, which binds to the subtype with M, 59,000 ACh-binding subunits, and mAb 285, which binds to the subtype with M, 75,000 AChbinding subunits, while mAb 270, which is directed to the common structural subunit, binds to both subtypes and Fig. 1) . Both mAbs 293 and 299 depleted approximately half the 3H-nicotine binding sites from detergent extracts of chicken brain (Fig. l) , as would be expected since western blot data (Table 1 ) demonstrated that they are directed to the ACh-binding subunit. mAbs 290, 291, 297, and 298 all depleted the majority of AChRs from chicken brain extracts (Fig. l) , suggesting that they are directed to determinants on the structural subunit, which is shared by both chicken brain AChR subtypes.
Several of the mAbs cross-react with AChRs from bovine and human brain (Table 1 ) and were used as biochemical probes to study these AChRs. Detergent extracts of bovine brain contained 0.19-0.35 nM 3H-nicotine binding sites (0.43-0.64 pmol/ gm brain; 5 preparations), and detergent extracts of human brain contained 0.05-O. 11 nM 3H-nicotine binding sites (0.05-0.2 1 pmol/gm brain; 7 preparations). The values for human brain cannot be considered representative of the number of 'H-nicotine binding sites in normal human brain because (1) the brains were from patients with Alzheimer's or Parkinson's disease, which are known to have reduced numbers of 3H-nicotine binding sites (Shimohama et al., 1986; Perry et al., 1987) , and (2) only portions of a whole brain were extracted in each preparation; these may be relatively richer or poorer in 3H-nicotine binding sites.
The pharmacology of AChRs from bovine and human brain was studied using the immimoimmobilization assay described previously (Whiting and Lindstrom, 1986b) . Figure 2 shows the binding of 3H-DL-nicotine to bovine and human brain AChRs immobilized upon mAb 290. Scatchard analysis of binding curves gave K, values of 2.6 + 0.3 x lo-* M (mean + SD; 2 determinations) for bovine brain AChR, and 9.7 ? 1.2 x 1O-9 M (mean f SD; 3 determinations) for human brain AChR. Additionally, the Kd value for 3H-DL-nicotine binding to bovine brain AChRs immobilized upon mAb 295 (not shown) was essentially identical to the Kd obtained using mAb 290, sugmAb Figure I . Depletion of AChRs from a detergent extract of chicken brain by mAbs to rat brain AChR. Triplicate aliquots (350 ~1) ofchicken brain detergent extract were gently shaken for 15 hr at 4°C with 50 ~1 of goat anti-rat IgG Sepharose and 5 rl of each mAb (titers shown in Table 1 ). The Sepharose was pelletted and the supernatants assayed for 3H-nicotine binding sites by a filter assay previously used by Schwartz et al. (1982) for studying 3H-ACh binding to rat brain membranes. Briefly, 100 ~1 triplicate aliquots of each supematant were incubated for 1 hr at 4°C with 20 nM 3H-nicotine and then diluted with 4 ml of ice-cold 50 mM Tris, pH 7.4, and filtered through Whatman GF/B filters presoaked in 0.3% polyethyleneimine. The filters were washed 3 times with 4 ml of the same buffer and bound radioactivity determined by scintillation counting. Nonspecific binding was determined by incubation in the presence of 1 mM nonradioactive nicotine and was subtracted. All values were expressed relative to the total 3H-nicotine binding sites (considered lOO%), determined by incubation with goat anti-rat IgG Sepharose alone.
gesting that the individual mAbs used here do not detectably affect the ligand-binding properties of the AChRs. Figure 3 shows the inhibition of 3H-nicotine binding to these AChRs by various cholinergic ligands. The K, values for these ligands are shown a Binding of mAbs to native AChR in detergent extracts ofbrain was determined by a previously described assay (Whiting and Lindstrom, 1986b, in Table 2 . AChRs from bovine and human brain exhibited high-affinity binding to L-nicotine and other choline& agonists, and relatively lower affinities to cholinergic antagonists. 3H-Nicotine binding was not inhibited by micromolar concentrations of aBgt. The aliquots were washed twice with 1 ml PBS, 0.5% Triton X-100, and incubated for 15 min at room temperature with 100 ~1 of the same buffer containing 10 nM 3H-nicotine, and various concentrations of competing ligands. Aliquots were rapidly washed 3 times with 1 ml PBS containing 0.5% Triton X-100, and bound radioactivity was determined as described in Materials and Methods. Each point is the mean ? SD of values from 3 aliquots. Nonspecific binding was determined by incubation in the absence of mAb 290, and has been subtracted. All values are expressed relative to the 'H-nicotine bound in the absence of competing ligand (considered 100%). Symbols indicate cytisine (0) L-nicotine (A), ACh m), carbachol (0) and tubocurare (0). Afinity-labeling of bovine and human brain AChRs with bromoacetylcholine and MBTA Bromoacetylcholine (BAC) and MBTA are nicotinic cholinergic affinity-labeling reagents that react with the AChR only after reduction of a disulfide bond between cysteine residues at positions 192 and 193 of the a: subunit of Torpedo AChR, which are adjacent to the ACh binding site (Kao et al., 1984) . We have previously shown that AChRs from chicken and rat brain can also be affinity-labeled with BAC and MBTA . Figure 4 demonstrates that AChRs from bovine and human brain can be affinity-labeled by BAC and MBTA after reduction with dithiothreitol (DTT). BAC was approximately 1000 times more effective than MBTA at affinitylabeling brain AChRs. 
Sucrose gradient analysis of AChRs
The macromolecular size of AChRs detergent-solubilized from bovine and human brain was analyzed by sucrose density-gradient centrifugation. Detergent-solubilized AChRs sedimented as single species slightly larger than Torpedo AChR monomers (Fig. 5) indicating that they are similar in size to AChRs from chicken brain (Whiting and Lindstrom, 1986a) and rat brain . Evidence suggests that AChRs from brains of chickens and rats have the subunit composition LY~&~-~ (Whiting et al., 1987b, c) , and this is probably true of AChRs from cattle and humans.
Structural characterization of AChR from bovine brain
We have used the same approach to immunoafinity-purify AChRs from bovine brain that was previously successful with AChRs from brains ofchickens (Whiting and Lindstrom, 1986a; Whiting et al., 1987~) and rats . Attempts to structurally characterize AChRs from human brain were not successful; when AChR from human brain was analyzed by probing western blots of the immunoaffinity-purified AChR with mAbs, or by affinity-labeling immunoimmobilized AChRs with 3H-MBTA and analyzing these by SDS-PAGE and fluorography, multiple bands were observed (data not shown). This suggested degradation of the AChR, probably during the postmortem period before the brain was removed and frozen.
AChR from bovine brain was immunoaffinity-purified on mAb 295 coupled to AFC resin (Table 3 ). This immunoaffinity column efficiently bound AChR from Triton X-100 extracts of bovine brain membranes. However, AChR eluted from the column using the AFC elution medium (supplied by New Brunswick Scientific) resulted in loss of 3H-nicotine binding activity, presumably because of denaturation of the AChR during the elution procedure. We have previously found that denaturation also occurs when AChR is eluted from immunoaffinity columns using a low-pH buffer Lindstrom, 1986a, 1987a) .
SDS-PAGE analysis and subsequent silver-staining demonstrated that AChRs from bovine brain consist of 2 types of subunit: A& 50,600 + 700 (mean -t SD; 4 determinations) and M, 74,400 + 1600 (mean f SD; 4 determinations) (Fig. 6A) . This same subunit pattern is also observed when the purified AChR is radioiodinated and analyzed by SDS-PAGE and subsequent autoradiography (Fig. 6B) . When western blots of bovine brain AChR were probed with mAb 268 (directed to the m -11-10 -9 -8 -7 -6 -5 -4 B -10 -9
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Log [Affinity Ligand] CM) Figure 4 . Affinity-labeling of (A) bovine brain AChR and (B) human brain AChR with BAC (0) and MBTA (A). Aliquots of detergent extracts of (4) bovine brain (2.50 ~1) or (B) human brain (400 ~1) were gently shaken for 15 hr at 4°C with 20 ~1 of goat anti-rat IgG Sepharose and 0.5 ~1 of mAb 290. The immunoimmobilized AChRs were then affinitylabeled as described elsewhere . Briefly, aliquots were washed twice with 1 ml PBS, 0.5% Triton X-100, then reduced for 40 min at room temperature with 200 ~1 of the same buffer, containing 1 mM DTT. Aliquots were washed with 1 ml PBS, 0.5% Triton X-100, and incubated for 5 min at room temperature in 100 ~1 of the same buffer, containing various concentrations of BAC or MBTA. The aliquots were washed 3 times with 1 ml of PBS, 0.5% Triton X-100, reoxidized by incubation for 10 min at room temperature with 200 ~1 of 0.1 mM dithiobis (2-nitrobenzoic acid) in PBS, 0.5% Triton X-100, and then washed twice with a further 1 ml PBS, 0.5% Triton X-100. The aliquots were then labeled with 20 nM 3H-nicotine and the 3H-nicotine binding sites determined as described in Materials and Methods. A parallel incubation was carried out, in which the affinity-labeling step was omitted, 3H-nicotine binding was considered as 100% and all other values were expressed relative to this. Nonspecific binding of 3H-nicotine was determined by incubation in the absence of mAb 290, and was subtracted. Each point is the mean of triplicate aliquots. structural subunit of AChRs from chicken and rat brain; Whiting et al., 1987~) binding to the 50,000 M, subunit was observed (Fig. 6C) , suggesting that it is the structural subunit of AChRs from bovine brain. Figure 5 . Sucrose gradient analysis of (A) bovine and (B) human brain AChR. Two milliliters of (A) bovine or (B) human brain detergent extract were loaded onto a 5-20% (wt/vol) sucrose gradient (in 10 mM Na phosphate, pH 7.5, 0.1% Triton X-100) and centrifuged for 4% hr in a VT150 Beckman rotor at 4°C at 50,000 rpm. 40-drop (A) or 60-drop (B) fractions were collected and assayed directly for 3H-nicotine binding by incubation with 20 pl goat anti-rat IgG Sepharose and 0.5 ~1 mAb 290, as described in Materials and Methods. As a standard, 12SI-aBgt-labeled Torpedo AChR was subjected to sucrose-gradient centrifugation in parallel and the fractions collected; radioactivity was determined by r-counting.
To determine which subunit contained the ACh binding site, immunoimmobilized AChR from bovine brain was affinity-labeled with 3H-MBTA and analyzed by SDS-PAGE and fluorography (Fig. 60) . The 74,000 A$ subunit was specifically labeled, suggesting that it contains the ACh binding site, and residues homologous to cysteines 192 and 193 of the (Y subunit of Torpedo AChR. The minor component at A& 56,200 may be a degradation product of the 74,000 M, polypeptide. Altematively, its size is similar to that of the ACh-binding subunit of chick ganglionic AChRs (Halvorsen and Berg, 1987) and to a putative ACh-binding subunit of a minor AChR subtype cDNA, (Y*, identified in rat brain (Wada et al., 1987) . We also observed a similar minor affinity-labeled band in AChR purified from rat brain . Thus, the affinity-labeled component at M, 56,200 could derive from traces of a copurified AChR subtype.
To further analyze the structure of AChR from bovine brain, the purified protein was radioiodinated and the 2 polypeptides isolated by preparative SDS-PAGE (Fig. 7A ). When digested with endoglycosidase-H, the structural subunit decreased in size by approximately 2000 (Fig. 7B) , indicating that, like the (Y subunit of AChRs from Torpedo (Gershoni et al., 1983) , muscle (Merlie et al., 1982) , chicken brain (Whiting and Lindstrom, 1986b) , and rat brain , it has mannose-rich oligosaccharide side chains. By contrast, there was no obvious change in the size of the ACh-binding subunit.
To investigate any obvious homologies between the structural and ACh-binding subunits, the isolated polypeptides were subjected to Staphylococcus V8 protease peptide mapping (Fig. 70 . The peptide maps of the 2 subunits were somewhat similar in their pattern, suggesting considerable homology.
Discussion
We have reported here the characterization of AChRs from bovine and human brain using mAbs prepared to AChRs from rat brain. This has been the third step in the process of using mAbs as probes for AChRs from fish to humans, to help follow the evolutionary tree: mAb 35 prepared to AChRs from Electrophorus electric organ (Tzartos et al., 1981) was used as a probe for AChRs from chicken brain (Whiting and Lindstrom, 1986a) ; mAb 270, prepared to AChRs from chicken brain (Whiting et al., 1987c) , was used as a probe for AChRs from rat brain . Now, mAbs 290 and 295, prepared to AChRs from rat brain, have been used as probes for AChRs from bovine and human brains.
The AChRs from bovine and human brains are similar to the AChRs from chicken and rat brains. All exhibit high-affinity binding for L-nicotine and other cholinergic agonists, relatively lower affinity binding for antagonists, and do not bind aBgt (Table 2) (Whiting and Lindstrom, 1986b; Whiting et al., 1987~) . However, the affinity of the AChR from bovine brain for L-nicotine (Ki = 16 nM) was somewhat lower than the affinities of AChRs from chicken brain (Ki = 1.1 and 1.6 nM for the 2 AChR subtypes; Whiting et al., 1987c) , rat brain (K, = 1.3 nM; Whiting et al., 1987d) , and human brain (K, = 6.5 nM) for this ligand.
Like AChRs from chicken and rat brain LindStrom, 1986b, 1987b) , AChRs from bovine and human brain were affinity-labeled with BAC and MBTA, demonstrating that they have cysteine residues homologous to cysteines 192 and 193 of the o( subunit of Torpedo AChR (Kao et al., 1984) . Molecular-weiaht markers (A, BioRad markers; B-D, Sigma prestained markers) are indicated by the side of each laneto the ACh binding site. BAC (an agonist) was a much more effective affinity label than MBTA (an antagonist), which probably reflects the relatively higher (nM) affinity of these brain AChRs for agonists than for antagonists. This is in contrast to ganglionic-type nicotinic AChRs, such as those found in PC 12 cells, where MBTA is a more effective affinity label than BAC, again probably reflecting the lower (PM) affinity of those ganglionic-type AChRs for agonists (Leprince, 1983) .
The subunit structure of the AChR from bovine brain (Fig.  6 ) is similar to that of the AChR subtype from chicken brain, with ACh-binding subunits ofA& 75,000 and to the AChR from rat brain . The structural subunit of AChR from bovine brain is homologous to structural subunits of AChRs from chicken and rat brains, as demonstrated by the essentially identical M, of the polypeptides, and the cross-reactivity of mAb 268 on western blots (Fig. 6) . Similarly, the 74,400 M, ACh-binding subunit of AChRs from bovine brain is homologous to the 79,000 M, AChbinding subunit of AChRs from rat brain and to the 75,000 M, ACh-binding subunit of one AChR subtype of chicken brain as demonstrated by their very similar M,s and by the fact that they are all labeled by 3H-MBTA (Fig. 6) . It is also possible to tentatively assign the same 2-subunittype structure to the nicotinic AChR from human brain; when western blots of AChR from human brain were probed with mAb 268, binding was detected, although to multiple bands, suggesting degradation of a structural subunit (data not shown). Similarly, when AChR from human brain was affinity-labeled with 3H-MBTA and analyzed by SDS-PAGE and fluorography, specific labeling of several polypeptides was observed, the largest of which was M, 79,000, which would be the predicted size of the ACh-binding subunit (data not shown). It has not been possible to gather more convincing evidence on the structure of AChRs from human brain, owing to degradation of the protein, which probably occurred during the postmortem period before the brain was removed and frozen. The proteolytic nicking of these AChRs probably did not affect their pharmacological properties; Torpedo electric organ AChR, digested with proteases, remains fully functional in carbachol-induced 22Na+ flux . Birds and mammals may differ in their distribution of AChR subtypes. In adult chicken brain we found approximately equal amounts of 2 subtypes, differing in their ACh-binding subunits (Whiting et al., 1987c) . In zebra finch brains there is immunohistological evidence for 2 similar subtypes (Watson et al., 1988) . However, in both rat brain and bovine brains (Fig. 6) , a predominant AChR subtype is observed corresponding to the chicken subtype with AChbinding subunits of M, 75,000. Another structure that is conserved in AChR from avian brain, but not in AChRs from mammalian brain, is the main immunogenic region (MIR). This is a domain on the extracellular surface of the a! subunit of electric organ and muscle AChRs against which the majority of antibodies are directed in an immune response to AChRs (Tzartos and Lindstrom, 1980) . mAbs directed to the MIR, such as mAb 35 (Tzartos et al., 198 l) Lindstrom, 1986b , human brain , or bovine brain (data not shown).
It is interesting to note that mAb 35 has recently been demonstrated as binding to the ganglionic-type nicotinic AChR of bovine adrenal chromaffin cells (Higgins and Berg, 1987) . Because mAb 35 does not bind to the AChR from bovine brain, it is clear that the AChRs from bovine brain and ganglia are antigenically somewhat different. In the future, comparison of the pharmacology and subunit structures ofthese 2 AChRs should prove informative.
The antigenic differences between ganglionic and brain AChRs suggest that at least one of their subunits is the product of different, but closely related, genes. This has been suggested previously by the observation that the AChRs of chick ciliary ganglia (Halvorsen and Berg, 1986 ) and PC12 cells (Kemp and Morley, 1986; Whiting et al., 1987d) have considerably lower affinities for nicotine and ACh compared to the nanomolar affinity of brain AChRs for these ligands (Whiting and Lindstrom, 1986b) . The concept of a nicotinic AChR gene family has been discussed previously (Conti-Tronconi et al., 1985; Boulter et al., 1986; Goldman et al., 1986 Goldman et al., , 1987 Whiting and Lindstrom, 1987~; . Recent data indicate that a much larger "super" gene family exists (Grenningloh et al., 1987; Schofield et al., 1987; for review, see Linstrom et al., 1987) . This gene family certainly includes the (Y, p, y, 6, and c subunits of the electric organ and muscle-type AChR. It also includes the putative neural AChR gene a2 , ot3 (Boulter et al., 1986) , a4 (Goldman et al., 1987; Nef et al., 1988) , and @2 or ncy Nef et al., 1988) . The cDNAs termed a4 have been shown to code for the M, 75,000 (chicken) and M, 79,000 (rat) ACh-binding subunits ; P. J. Whiting, F. Esch, and J. M. Lindstrom, unpublished observations) of neuronal AChRs with high affinity for nicotine. The cDNAs p2 (rat) and ncy (chicken) have been shown to code for the structural subunit of AChRs from chicken and rat brain which have high affinity for nicotine (Schoepfer et al., 1988) . The identities of the proteins coded for by a2 and (r3 have yet to be established. It is possible that (r3 is the ACh-binding subunit of the ganglionic-type AChR of PC 12 cells and chick ciliary ganglion neurons (Boulter et al., 1986; Boyd et al., 1987) . Ganglionic AChRs may, however, have the same structural subunit (coded for by cDNAs p2 and ncu) as the brain-type AChRs, as is suggested by the fact that p2 was isolated from PC12 cells , and mAb 270, which is directed to the structural subunit, binds to AChRs of PC12 cells (Whiting et al., 1987d) . The identity of the subunit coded for by cDNA ot2 remains obscure. At the protein level, although we have clear evidence of AChR subtypes in chicken brain we have as yet only limited evidence for multiple AChR subtypes in mammalian brains (e.g., the minor affinity-labeled band in Fig. 6 , or see neuronal AChRs both at the molecular level and at the level of synaptic transmission and brain function. Many different approaches will be required to resolve these issues.
